News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioMidwest
Vertex Pharmaceuticals Incorporated Announces Acceptance of Telaprevir and VCH-222 Abstracts for Presentation at EASL Annual Meeting
March 18, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CHICAGO--(BUSINESS WIRE)--2009 iBIO IndEx takes place today at the Hyatt Regency Chicago in Chicago.
Twitter
LinkedIn
Facebook
Email
Print
Events
Vertex Pharmaceuticals
MORE ON THIS TOPIC
Podcast
Lilly tees off with Novo at ADA, GSK’s $10.6B deal, FDA reform continues in Makary’s absence
June 10, 2026
·
2 min read
·
Jef Akst
Diabetes
ADA: Lilly bests Novo again, takes GLP-1 pill Foundayo to FDA for diabetes approval
June 9, 2026
·
2 min read
·
Tristan Manalac
Obesity
ADA: Novo boasts deep pipeline, ‘breadth of assets’ after analysts award Lilly weight loss gold
June 8, 2026
·
5 min read
·
Heather McKenzie
Obesity
ADA: Boehringer leans on fat mass benefits as obesity bet delivers ‘less competitive’ weight reduction
June 8, 2026
·
2 min read
·
Tristan Manalac
